vs

Side-by-side financial comparison of Neuronetics, Inc. (STIM) and Veris Residential, Inc. (VRE). Click either name above to swap in a different company.

Veris Residential, Inc. is the larger business by last-quarter revenue ($70.1M vs $41.8M, roughly 1.7× Neuronetics, Inc.). Neuronetics, Inc. runs the higher net margin — -17.2% vs -20.0%, a 2.7% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 3.5%). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 1.9%).

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

Veris Residential, Inc. is an American real estate investment trust headquartered in Jersey City, New Jersey, investing primarily in apartments in New Jersey and Boston.

STIM vs VRE — Head-to-Head

Bigger by revenue
VRE
VRE
1.7× larger
VRE
$70.1M
$41.8M
STIM
Growing faster (revenue YoY)
STIM
STIM
+82.3% gap
STIM
85.7%
3.5%
VRE
Higher net margin
STIM
STIM
2.7% more per $
STIM
-17.2%
-20.0%
VRE
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
1.9%
VRE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
STIM
STIM
VRE
VRE
Revenue
$41.8M
$70.1M
Net Profit
$-7.2M
$-14.0M
Gross Margin
52.0%
95.9%
Operating Margin
-12.1%
-22.2%
Net Margin
-17.2%
-20.0%
Revenue YoY
85.7%
3.5%
Net Profit YoY
43.2%
-30.9%
EPS (diluted)
$-0.10
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STIM
STIM
VRE
VRE
Q1 26
$70.1M
Q4 25
$41.8M
$71.3M
Q3 25
$37.3M
$73.4M
Q2 25
$38.1M
$75.9M
Q1 25
$32.0M
$67.8M
Q4 24
$22.5M
$68.1M
Q3 24
$18.5M
$68.2M
Q2 24
$16.4M
$67.5M
Net Profit
STIM
STIM
VRE
VRE
Q1 26
$-14.0M
Q4 25
$-7.2M
$-203.0K
Q3 25
$-9.0M
$75.2M
Q2 25
$-10.1M
$10.9M
Q1 25
$-12.7M
$-10.7M
Q4 24
$-12.7M
$-12.4M
Q3 24
$-13.3M
$-9.7M
Q2 24
$-9.8M
$2.9M
Gross Margin
STIM
STIM
VRE
VRE
Q1 26
95.9%
Q4 25
52.0%
97.2%
Q3 25
45.9%
96.8%
Q2 25
46.6%
97.2%
Q1 25
49.2%
95.9%
Q4 24
66.2%
97.1%
Q3 24
75.6%
96.9%
Q2 24
74.0%
97.3%
Operating Margin
STIM
STIM
VRE
VRE
Q1 26
-22.2%
Q4 25
-12.1%
-0.9%
Q3 25
-19.6%
Q2 25
-21.1%
15.8%
Q1 25
-34.4%
-20.4%
Q4 24
-51.0%
-21.9%
Q3 24
-41.7%
-16.2%
Q2 24
-51.7%
2.2%
Net Margin
STIM
STIM
VRE
VRE
Q1 26
-20.0%
Q4 25
-17.2%
-0.3%
Q3 25
-24.3%
102.4%
Q2 25
-26.6%
14.4%
Q1 25
-39.6%
-15.8%
Q4 24
-56.4%
-18.3%
Q3 24
-72.0%
-14.2%
Q2 24
-59.8%
4.3%
EPS (diluted)
STIM
STIM
VRE
VRE
Q1 26
$-0.15
Q4 25
$-0.10
$0.00
Q3 25
$-0.13
$0.80
Q2 25
$-0.15
$0.12
Q1 25
$-0.21
$-0.12
Q4 24
$-0.34
$-0.14
Q3 24
$-0.44
$-0.10
Q2 24
$-0.33
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STIM
STIM
VRE
VRE
Cash + ST InvestmentsLiquidity on hand
$28.1M
$9.4M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$22.4M
$1.1B
Total Assets
$141.6M
$2.7B
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STIM
STIM
VRE
VRE
Q1 26
$9.4M
Q4 25
$28.1M
$14.1M
Q3 25
$28.0M
$8.8M
Q2 25
$11.0M
$11.4M
Q1 25
$20.2M
$7.6M
Q4 24
$18.5M
$7.3M
Q3 24
$20.9M
$12.8M
Q2 24
$42.6M
$18.4M
Total Debt
STIM
STIM
VRE
VRE
Q1 26
Q4 25
$65.8M
$1.4B
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
$1.7B
Q3 24
$46.0M
Q2 24
$59.8M
Stockholders' Equity
STIM
STIM
VRE
VRE
Q1 26
$1.1B
Q4 25
$22.4M
$1.2B
Q3 25
$27.4M
$1.2B
Q2 25
$27.1M
$1.1B
Q1 25
$35.5M
$1.1B
Q4 24
$27.7M
$1.1B
Q3 24
$9.4M
$1.1B
Q2 24
$19.4M
$1.1B
Total Assets
STIM
STIM
VRE
VRE
Q1 26
$2.7B
Q4 25
$141.6M
$2.7B
Q3 25
$145.5M
$2.8B
Q2 25
$134.7M
$3.1B
Q1 25
$142.0M
$3.0B
Q4 24
$140.9M
$3.0B
Q3 24
$3.0B
Q2 24
$96.8M
$3.0B
Debt / Equity
STIM
STIM
VRE
VRE
Q1 26
Q4 25
2.94×
1.18×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
1.52×
Q3 24
4.90×
Q2 24
3.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STIM
STIM
VRE
VRE
Operating Cash FlowLast quarter
$908.0K
$14.0M
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STIM
STIM
VRE
VRE
Q1 26
$14.0M
Q4 25
$908.0K
$76.0M
Q3 25
$-785.0K
$13.5M
Q2 25
$-3.5M
$23.8M
Q1 25
$-17.0M
$13.2M
Q4 24
$-8.6M
$52.3M
Q3 24
$-5.4M
$13.9M
Q2 24
$-5.0M
$10.8M
Free Cash Flow
STIM
STIM
VRE
VRE
Q1 26
Q4 25
$692.0K
Q3 25
$-899.0K
Q2 25
$-3.8M
Q1 25
$-17.2M
Q4 24
$-8.7M
Q3 24
$-5.8M
Q2 24
$-5.6M
FCF Margin
STIM
STIM
VRE
VRE
Q1 26
Q4 25
1.7%
Q3 25
-2.4%
Q2 25
-9.9%
Q1 25
-53.8%
Q4 24
-38.6%
Q3 24
-31.3%
Q2 24
-34.0%
Capex Intensity
STIM
STIM
VRE
VRE
Q1 26
Q4 25
0.5%
Q3 25
0.3%
Q2 25
0.7%
Q1 25
0.7%
Q4 24
0.4%
Q3 24
2.1%
Q2 24
3.7%
Cash Conversion
STIM
STIM
VRE
VRE
Q1 26
Q4 25
Q3 25
0.18×
Q2 25
2.18×
Q1 25
Q4 24
Q3 24
Q2 24
3.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons